Anita Rozsas

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Machine Learning-enhanced X-ray-based Radiomics in the Identification of Post-COVID Patients.

Machine Learning-enhanced X-ray-based Radiomics in the Identification of Post-COVID Patients.

Journal: Archivos de bronconeumologia

Published: September 04, 2024

Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer.

Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer.

Journal: Current opinion in oncology

Published: November 24, 2022

The impact of the COVID-19 epidemic on the course of the most common respiratory diseases

The impact of the COVID-19 epidemic on the course of the most common respiratory diseases

Journal: Orvosi hetilap

Published: September 19, 2022

Clinical relevance of circulating activin A and follistatin in small cell lung cancer.

Clinical relevance of circulating activin A and follistatin in small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 13, 2021

Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.

Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 17, 2016

High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.

High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.

Journal: Oncotarget

Published: November 20, 2015

Excerpts from the collaborative lung cancer research program of Semmelweis University, the National Institute of Oncology and Korányi Institute of TB and Pulmonology (2010-2015)

Excerpts from the collaborative lung cancer research program of Semmelweis University, the National Institute of Oncology and Korányi Institute of TB and Pulmonology (2010-2015)

Journal: Magyar onkologia

Published: November 10, 2015

Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.

Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.

Journal: Molecular cancer therapeutics

Published: October 21, 2015

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.

Journal: British journal of cancer

Published: March 25, 2015

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma.

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 10, 2015

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.

Journal: British journal of cancer

Published: December 19, 2014

Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.

Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.

Journal: The Journal of pathology

Published: September 21, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026